Public Reporting

ACO Name and Location

Think ACO, LLC
Previous Names: N/A
7100 West Center Road
Omaha, NE 68106

ACO Primary Contact

Primary Contact Name Tim Thompson
Primary Contact Phone Number 531.222.8855
Primary Contact Email Address tim.thompson@thinkhealthcare.org

Organizational Information

ACO participants:

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Think Aksarben, LLC No

ACO governing body:

Member Last Name Member First Name Member Title/Position Member’s Voting Power – Expressed as a percentage or number Membership Type ACO Participant Legal Business Name/DBA, if Applicable
Canedy Jim ACO Executive 1 ACO participant representative Think Aksarben, LLC
Engle William Medical Director 1 ACO participant representative Think Aksarben, LLC
Mancuso Martin Physician 1 ACO participant representative Think Aksarben, LLC
Recker Robert Physician 1 ACO participant representative Think Aksarben, LLC
Weeks William Physician 1 ACO participant representative Think Aksarben, LLC
Dunn Michael Retired Physician 1 Medicare beneficiary representative  

Key ACO clinical and administrative leadership:

ACO Executive Jim Canedy, MD
Medical Director William Engle, DO
Compliance Officer Mike Demman
Quality Assurance/Improvement Officer Amanda Payne

Associated committees and committee leadership:

Committee Name Committee Leader Name and Position
Population Health William Engle, DO, Medical Director
Quality Assurance and Quality Improvement Amanda Payne, QA/QI Professional
Compensation/Gainshare Committee Jason Doll, Chief Operating Officer

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Second Agreement Period
    • Performance Year 2020, $1,493,375.13
    • Performance Year 2019, $2,843,195.84
  • First Agreement Period
    • Performance Year 2019, $2,843,195.84
    • Performance Year 2018, $0
    • Performance Year 2017, $2,412,663
    • Performance Year 2016, $0

Note: Our ACO participated in multiple performance years during Calendar Year 2019. Shared savings amount reported for Performance Year 2019 therefore represents net shared savings across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.

Shared Savings Distribution

  • Second Agreement Period
  • Performance Year 2020
    • Proportion invested in infrastructure: 0%
    • Proportion invested in redesigned care processes/resources: 0%
    • Proportion of distribution to ACO participants: 100%
  • Performance Year 2019
    • Proportion invested in infrastructure: 0%
    • Proportion invested in redesigned care processes/resources: 0%
    • Proportion of distribution to ACO participants: 100%
  •  
  • First Agreement Period
  • Performance Year 2019
    • Proportion invested in infrastructure: 0%
    • Proportion invested in redesigned care processes/resources: 0%
    • Proportion of distribution to ACO participants: 100%
  • Performance Year 2018
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2017
    • Proportion invested in infrastructure: 0%
    • Proportion invested in redesigned care processes/resources: 0%
    • Proportion of distribution to ACO participants: 100%
  • Performance Year 2016
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A

Note: Our ACO participated in multiple performance years during Calendar Year 2019. Distribution of shared savings reported for Performance Year 2019 therefore represents the distribution of the net shared savings across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.

Quality Performance Results

2020 Quality Performance Results:

ACO#       Measure Name Rate ACO Mean
ACO-43 Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) .66 .95
ACO-13 Falls: Screening for Future Fall Risk96.77 96.77 84.97
ACO-14 Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) 95.08 76.03
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 75.86 81.67
ACO-18 Preventive Care and Screening: Screening for Depression and Follow-up Plan 90.12 71.46
ACO-19 Colorectal Cancer Screening 84.54 72.59
ACO-20 Breast Cancer Screening 88.87 74.05
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 88.80 83.37
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 6.41 14.70
ACO-28 Hypertension (HTN): Controlling High Blood Pressure 83.19 72.87

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-day Rule Waiver:
    • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR §425.612.
  • Waiver for Payment for Telehealth Services:
    • Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR §425.612(f) and 42 CFR §425.613.